www.spectrumnanotech.com Open in urlscan Pro
18.157.120.97  Public Scan

URL: https://www.spectrumnanotech.com/
Submission: On July 23 via automatic, source certstream-suspicious — Scanned from DE

Form analysis 0 forms found in the DOM

Text Content

888-377-7328
sbalsten@spectrumspine.com
 
* 
* 
 * Home
 * Our Story
 * Technology
 * Executive Team
 * Advisory Board
 * Investor Information
 * Contact Us
 * …  
   * Home
   * Our Story
   * Technology
   * Executive Team
   * Advisory Board
   * Investor Information
   * Contact Us


888-377-7328
sbalsten@spectrumspine.com
 
* 
* 
 * Home
 * Our Story
 * Technology
 * Executive Team
 * Advisory Board
 * Investor Information
 * Contact Us
 * …  
   * Home
   * Our Story
   * Technology
   * Executive Team
   * Advisory Board
   * Investor Information
   * Contact Us




 *  
   
    
   
    
   
   
   BIOBRAILLE: A STUNNING DISRUPTIVE SURFACE TECHNOLOGY FOR ORTHOPEDIC AND
   SPINAL IMPLANTS THAT INDUCES NEW BONE GROWTH WITH INCREDIBLE RAPIDITY
   
   GET BACK YOUR QUALITY OF LIFE, BETTER, AND FASTER... WITH SPECTRUM SPINE
   
   View Technology

 *  
   
   
   PROBLEM WORTH SOLVING
   
   
   EVERY YEAR, 1 IN 8 PEOPLE RECEIVE TREATMENT FOR SPINE ISSUES, AND 1 IN 5
   SPINE SURGERY PATIENTS DEVELOP A NARCOTICS ADDICTION. DESPITE THIS, MOST
   LEADING SPINE IMPLANT COMPANIES ARE NOT INNOVATING. WE HAVE DEVELOPED AND
   FDA-CLEARED GROUNDBREAKING SOLUTIONS FOR SPINE SURGERY, INCLUDING A
   DISRUPTIVE SURFACE TREATMENT POISED TO REVOLUTIONIZE THE $5 BILLION U.S. BONE
   GRAFT MARKET.
   
    
   
   
   DELIVERING INNOVATIVE SPINAL SURGERY SOLUTIONS TO SURGEONS AND THEIR PAITENTS
   
   


 * BIOBRAILLE: INNOVATIVE SURFACE TECHNOLOGY FOR BONE GROWTH
   
   BIOBRAILLE™ IS A REVOLUTIONARY SURFACE TECHNOLOGY THAT LEVERAGES THE BODY'S
   NATURAL MECHANISMS TO GROW NEW BONE BY "READING" THE INSTRUCTIONS IN ITS
   MACROSCOPIC, MICROSCOPIC, AND NANOMETER-SCALE FEATURES. THIS TECHNOLOGY
   PROMOTES RAPID AND VIBRANT BONE FORMATION WITHOUT THE NEED FOR EXPENSIVE AND
   POTENTIALLY HAZARDOUS BONE GRAFTS OR SYNTHETIC MATERIALS. BIOBRAILLE™ HAS
   BROAD APPLICATIONS IN THE $55B GLOBAL SPINE, ORTHOPEDIC, AND DENTAL IMPLANT
   MARKETS.
   
   
   CERVICAL CAGE DEVICE
   
   Interbody cages are structural supports that stabilize the spine and have a
   hollow to allow for bone growth through the middle. These cages have special
   design features to facilitate our surface treatment that stimulates bone
   growth in a manner never seen before, promising to reduce or prevent the need
   for expensive and potentially dangerous bone graft products. Anterior
   cervical fusion procedures are among the most common spine procedures. This
   system is FDA cleared and initial cases are scheduling now!
   
   More Information
   
   
   LUMBAR CAGE DEVICES
   
   Low back fusion procedures can be done through surgical approaches from
   different angles. These are called Posterior or Transforamenal Interbody
   Fusions (PLIF or TLIF), Anterior Lumbar Interbody Fusion (ALIF) and Direct
   Lateral Interbody Fusion (DLIF). Our complete family of lumbar cages are in
   the FDA process and we expect clearance to sell from the FDA soon and will be
   ready for commercial sales.
   
   More Information


 * EXECUTIVE TEAM
   
   
   
   
   JIM ROBINSON, MD, MBA- CEO/FOUNDER
   
   AFTER 20+ YEARS DRIVING THE CLINICAL EVOLUTION OF MINIMALLY INVASIVE
   SURGERIES, DR. ROBINSON OBSERVED THE MEDICAL DEVICE INDUSTRY’S BIAS SHIFT
   FROM TECHNOLOGY-BASED DEVICE DEVELOPMENT TOWARD COPYCAT DEVICES, AND VALUING
   SALES OVER INNOVATION. KNOWING HIS IDEAS COULD IMPROVE PATIENT OUTCOMES BY
   FURTHER REDUCING THE TISSUE DAMAGE THAT SLOWS THE BODY’S RECOVERY PROCESS, HE
   SPENT A SABBATICAL ACHIEVING HIS MBA AND DESIGNING THE PRODUCTS THAT HE
   ENVISIONED WOULD OVERCOME FRUSTRATIONS AND FAILURES OF THE AVAILABLE
   ALTERNATIVES. THE RESULT OF THAT TIME WAS A GRADUATION AT THE TOP OF HIS
   EMORY MBA CLASS, DOZENS OF PATENTS, AND 7 NEW SPINAL SURGICAL DEVICES READY
   FOR MARKETAND U.S. FDA CLEARED. THE TIME HAS NOW COME FOR THIS MATURE AND
   VALUABLE, SELF-FUNDED COLLECTION OF DEVICE SYSTEMS TO BE BROUGHT TO MARKET.
   WE WILL ALSO WORK CLOSELY WITH THE HIGHEST CALIBER SPINAL, ORTHOPEDIC AND
   ORAL SURGEONS TO CONTINUE TO INNOVATE, AND TO REMAIN AT THE PINNACLE OF
   TECHNOLOGY DEVELOPMENT.JIM IS ALSO ACTIVE WITH NON-PROFIT GROUPS AND HAS
   DONATED MUCH TIME WITHIN THE U.S. AND IN OTHER COUNTRIES PROVIDING EXPERT
   NEUROSURGICAL CARE TO THOSE IN NEED. HE IS ON THE BOARD OF DIRECTORS OF HOI,
   INC, AN NGO ACTIVE IN CENTRAL AMERICA, AND HAS BEEN A LEADER FOR YEARS IN THE
   BOY SCOUTS OF AMERICA.
   
   
   INSPIRING PATIENT STORY
   
   
   SCOTT BALTSEN- CHIEF OPERATING OFFICER
   
   SCOTT BALTSEN’S25 YEARS IN THE MEDICAL DEVICE INDUSTRY HAS BEEN FOCUSED ON
   COMMERCIALIZATION AND OPERATIONS FOR STARTUP COMPANIES WITH UNIQUE SOLUTIONS
   IN THE ORTHOPEDIC SPACE.HE WAS AN EARLY EMPLOYEE AT ARTHROSURFACE, THE
   INNOVATOR OF PARTIAL RESURFACING JOINT ARTHOPLASTY,WHICH HAD A SUCCESSFUL
   EXIT WITH ANIKA.THERE HE ESTABLISHED, ONBOARDED, AND MANAGED THEIR
   INDEPENDENT DISTRIBUTION NETWORK AND REGIONAL SALES MANAGERS. FOLLOWING
   ARTHROSURFACESCOTT WAS HIRED AS THE FIRST EMPLOYEE TO SET UP AND RUN THE US
   SUBSIDIARY FOR SYNTHETIC LIGAMENT INNOVATOR SURGICRAFT/LOCKDOWNMEDICAL,
   ESTABLISHING LOCKDOWNSURGICAL IN 2012 AND EFFICIENTLY MANAGING THE US
   OPERATIONS WITH MORE THAN 50 DISTRIBUTORS.THROUGHOUT HIS CAREER HE HAS WORKED
   WITH DISTRIBUTORS AND VENDORS IN US ANDINTERNATIONALLY WHILE REPRESENTEINGOR
   CONSULTING WITH BIOMET/ZIMMER, MICROAIRE, QUANTUM OPS, TENSOR, ALIGNMED,
   OSSUR, ORATEC, AND SURGICAL SOLUTIONS. HE RECEIVED HIS BS IN BIOMEDICAL
   ENGINEERING FROM THE JOHNS HOPKINS UNIVERSITY.
   
   
   PHIL POWELL- EXECUTIVE VP OF SALES
   
   FOUNDER OF ONE OF THE LARGEST MEDICAL DISTRIBUTORSHIPS IN THE COUNTRY,
   PHILLIP POWELL HAS OVER 23+ YEARS OF EXPERIENCE IN THE MEDICAL SALES AND
   DISTRIBUTION IN THE HEALTHCARE INDUSTRY. MR. POWELL’S SALES EXPERTISE AND
   EXPERIENCE AS A SALES EXECUTIVE IN THE HEALTHCARE AND TECHNOLOGY MARKETS LEAD
   HIM TO HIS SUCCESSES IN SELLING TECHNICAL TEAM SOLUTIONS AND SURGICAL
   INSTRUMENTS AND IMPLANTS TO THE ORTHOPEDIC MARKET.MR. POWELL IS A TRUSTED
   ADVISOR OF MANY ORGANIZATIONS AND HAS HELPED NUMEROUS SENIOR EXECUTIVES
   DEFINE AND EXECUTE STRATEGIES THAT HAVE PROVEN TO DOMINATE THE MARKET. HIS
   DEPENDABLE AND SELF-MOTIVATED CHARACTERISTICS ALONG WITH HIS ABILITY TO ADAPT
   TO CHANGING SITUATIONS LED HIM TO WORK WITH SOME OF THE LARGEST MEDICAL
   DEVICE MANUFACTURERS IN THE WORLD, DELIVERING RECORD SALES AND LAUNCHING
   COUNTLESS NEW PRODUCTS AND TECHNOLOGIES.PHILLIP IS A GRADUATE OF STEPHEN F
   AUSTIN STATE UNIVERSITY, WHERE HE EARNED A BACHELOR OF SCIENCE IN
   BUSINESS ADMINISTRATION. HE IS A PROUD MEMBER OF THE SIGMA CHI FRATERNITY AND
   A DEDICATED BASEBALL PLAYER IN HIS YEARS AT THE UNIVERSITY AND IS A PROUD
   FATHER OF THREE GIRLS. THROUGH HIS EDUCATION AND DECADES OF EXPERIENCE, MR.
   POWELL HAS BECOME A WELL-KNOWN NAME IN THE INDUSTRY AND UTILIZES HIS
   KNOWLEDGE AND SKILL TO BE AN INSPIRED LEADER WHO PAYS CLOSE ATTENTION TO
   DETAIL, PROVIDING ONGOING TRAINING AND IMPROVEMENT GOALS FOR HIS TEAM. 
   
   
   JIM SEVEY- CHIEF STRATEGY OFFICER
   
   MR. SEVEY WILL BE RESPONSIBLE FOR THE ORGANIZATIONAL STRATEGY AND INTEGRATION
   OF SPECTRUM’S PATENTED NANOTECHNOLOGY WHERE THE SURFACE TO TISSUE INTERFACE
   IS CRUCIAL FOR CLINICAL SUCCESS. MR. SEVEY JOINS SPECTRUM FROM MEDTRONIC
   WHERE HE SERVED AS SENIOR DIRECTOR OF A CLINICAL STRATEGY AND MANAGED THE
   TEAM ACCOUNTABLE FOR THE CLINICAL STRATEGY OF ALL NEW PRODUCT INNOVATIONS FOR
   THE CRANIAL AND SPINAL TECHNOLOGIES DIVISION. PRIOR TO MEDTRONIC, WHICH HE
   JOINED VIA THE ACQUISITION OF TITAN SPINE’S NANOTECHNOLOGY, JIM SERVED AS
   SENIOR DIRECTOR OF STRATEGIC PARTNERING AND SCIENTIFIC FIELD DEVELOPMENT FOR
   TITAN SPINE. MR. SEVEY BRINGS AN EXTENSIVE HISTORY OF START-UP EXPERIENCE AND
   MERGERS AND ACQUISITIONS IN NANOTECHNOLOGY, BIOLOGICS, SPINAL IMPLANTS,
   CRANIOMAXILLOFACIAL, CARDIOVASCULAR, ORTHOPEDIC TRAUMA, AND CLINICAL DATA
   DEVELOPMENT.


 * ADVISORY BOARD
   
   
   SURGEON ADVISORS, SCIENTIFIC ADVISORS, AND BUSINESS ADVISORS
   
   
   STEVE MCANANY, MD - ASSISTANT PROFESSOR AT THE HOSPITAL FOR SPEICAL SURERY
   
   DR. STEVEN MCANANY IS AN ASSISTANT ATTENDING ORTHOPEDIC SURGEON AT HSS AND
   CO-MEDICAL DIRECTOR FOR HSS SPINE CENTER WITH STAMFORD HEALTH. HE IS AN
   ASSISTANT PROFESSOR OF ORTHOPEDIC SURGERY AT WEILL CORNELL MEDICAL COLLEGE.
   DR. MCANANY'S RESEARCH INTERESTS LIE IN THE COST-EFFECTIVENESS ANALYSIS OF
   SPINE SURGERY, INCLUDING CERVICAL DISC REPLACEMENTS, DISCECTOMIES, FUSIONS
   AND MINIMALLY INVASIVE SURGERY. HE HAS AUTHORED OVER 50 ARTICLES, BOOK
   CHAPTERS, AND TEXT BOOKS. DR. MCANANY IS INVOLVED IN THE DESIGN OF INNOVATIVE
   SURGICAL TECHNOLOGY WITH AN EMPHASIS ON DEVELOPING IMPLANTS AND TECHNIQUES TO
   IMPROVE SURGICAL FUSION RATES. DR. MCANANY RECEIVED HIS MEDICAL DEGREE FROM
   MOUNT SINAI SCHOOL OF MEDICINE IN NEW YORK, NY, AND COMPLETED HIS ORTHOPEDIC
   SURGERY RESIDENCY AT MOUNT SINAI HOSPITAL. HE THEN COMPLETED FELLOWSHIP
   TRAINING IN SPINE SURGERY AT EMORY UNIVERSITY HOSPITAL IN ATLANTA, GEORGIA.
   DR. MCANANY IS A MEMBER OF THE NORTH AMERICAN SPINE SOCIETY, AMERICAN ACADEMY
   OF ORTHOPAEDIC SURGEONS, AND A REVIEWER FOR THE GLOBAL SPINE JOURNAL.
   
   
   ROBERT EASTLACK, MD - SPINE SURGERY DIVISION HEAD OF SCRIPPS CLINIC MEDICAL
   GROUP
   
   DR. EASTLACK WAS BORN IN WYOMING, AND GREW UP PRIMARILY IN ALASKA, BEFORE
   ATTENDING STANFORD UNIVERSITY. HE MAJORED IN HUMAN BIOLOGY WITH FOCUS ON
   NEUROPHYSIOLOGY, AND WHILE THERE WAS ON THE STANFORD MEN’S SWIMMING TEAM,
   SERVING AS CAPTAIN IN HIS SENIOR YEAR. AFTER FINISHING HIS UNDERGRADUATE
   STUDIES, HE STAYED AND JOINED THE RESEARCH TEAM IN THE CARDIOLOGY DEPARTMENT
   BEFORE ATTENDING MEDICAL SCHOOL NEARER HIS FAMILY IN TEXAS. FOLLOWING
   GRADUATION FROM BAYLOR COLLEGE OF MEDICINE, HE RETURNED TO CALIFORNIA, WHERE
   HE AND HIS WIFE BOTH MATCHED AT UCSD FOR THEIR RESIDENCY TRAINING. THE
   ORTHOPAEDIC SURGERY RESIDENCY WAS COMBINED WITH A YEAR OF RESEARCH
   FELLOWSHIP, AND UNDER THE TUTELAGE OF DR. STEVEN GARFIN, HE DECIDED UPON
   UNDERTAKING A SPINE FELLOWSHIP AT MAYO CLINIC IN ROCHESTER, MINNESOTA. UPON
   COMPLETION OF THE FELLOWSHIP, DR. EASTLACK RETURNED TO SAN DIEGO, WORKING
   WITH BOTH UCSD AND THE SAN DIEGO SPINE FOUNDATION FELLOWSHIP PROGRAMS, AS
   WELL AS THE UCSD ORTHOPEDIC SURGERY DEPARTMENT AS A CLINICAL INSTRUCTOR. IN
   2008, HE MOVED TO SCRIPPS CLINIC IN THE DIVISION OF ORTHOPEDIC SURGERY, AND
   CONTINUES TO SERVE AS A CONSULTANT THERE. HE ALSO ACTS AS CO-DIRECTOR FOR THE
   SPINE FELLOWSHIP TRAINING PROGRAM THAT IS MANAGED BY THE SAN DIEGO SPINE
   FOUNDATION. HE IS A MEMBER OF THE INTERNATIONAL SPINE STUDY GROUP, FOCUSED ON
   ADULT DEFORMITY AND MINIMALLY INVASIVE RESEARCH, AND UNDERTAKES CLINICAL AND
   BASIC SCIENCE RESEARCH AT SCRIPPS CLINIC AS WELL. HIS CLINICAL INTERESTS ARE
   IN CERVICAL RECONSTRUCTION, MINIMALLY INVASIVE SPINAL RECONSTRUCTION, AND
   COMPLEX DEFORMITY SURGERY. HIS WIFE JENNIFER EASTLACK IS A DERMATOLOGIST IN
   SAN DIEGO, AND THEY HAVE FIVE CHILDREN. HIS PERSONAL INTERESTS INCLUDE
   COACHING VARIOUS SPORTS TEAMS (BASEBALL, SOCCER, AND BASKETBALL) ON WHICH HIS
   CHILDREN PLAY AND PLAYING GOLF, AS WELL AS CO-MANAGING A LIFE SCIENCE FUND
   ANDMEDICAL DEVICE DEVELOPMENT.
   
   
   STEPHEN HOCHSCHULER, MD - FOUNDER AND CHAIRMAN OF EMERITUS TEXAS BACK
   INSTITUTE
   
   DR. STEPHEN HOCHSCHULER IS AN ORTHOPEDIC SURGEON AND CO-FOUNDER OF THE TEXAS
   BACK INSTITUTE. HE SPECIALIZES IN THE LUMBAR SPINE AND HAS BEEN A PRACTICING
   SPINE SURGEON FOR MORE THAN 40 YEARS. DR. HOCHSCHULER IS A LEADER IN SPINE
   MEDICINE, HAVING FOUNDED AND SERVED AS PRESIDENT FOR A NUMBER OF MEDICAL
   ASSOCIATIONS AND PROFESSIONAL SOCIETIES. HE HAS WRITTEN NUMEROUS ARTICLES
   PUBLISHED IN PEER-REVIEWED MEDICAL JOURNALS, SUCH AS THE SPINE JOURNAL,
   SPINE, AND THE JOURNAL OF NEUROSURGERY: SPINE, AND HAS DELIVERED HUNDREDS OF
   PRESENTATIONS AT MEDICAL CONFERENCES NATIONALLY AND INTERNATIONALLY. HE IS
   ACTIVELY INVOLVED IN PATIENT EDUCATION. HE FOUNDED ONE OF THE FIRST BACK
   SCHOOLS TO EDUCATE PATIENTS ABOUT SPINE CARE AND HAS EDITED AND CONTRIBUTED
   TO DOZENS OF BOOKS ON BACK CONDITIONS AND TREATMENTS. DR. HOCHSCHULER IS A
   MEDICAL ADVISOR FOR VERITAS HEALTH, PROVIDING OVERSIGHT TOENSURE THE ACCURACY
   AND QUALITY OF ITS ARTICLES. STEPHEN HOCHSCHULER HAS AN IMPRESSIVE ARRAY OF
   PROFESSIONAL MEMBERSHIPS AND ACHIEVEMENTS. HE HAS SERVED AS THE PAST
   PRESIDENT OF THE SPINE ARTHROPLASTY SOCIETY AND THE PAST PRESIDENT OF THE
   INTERNATIONAL SOCIETY FOR THE ADVANCEMENT OF SPINE SURGERY. ADDITIONALLY, HE
   FOUNDED THE SPINE DIVISION AT THE VETERANS ADMINISTRATION AND IS A FOUNDING
   MEMBER OF THE AMERICAN BOARD OF SPINE SURGERY. HE IS ALSO A MEMBER OF THE
   NORTH AMERICAN SPINE SOCIETY AND THE AMERICAN ACADEMY OF ORTHOPAEDIC
   SURGEONS.
   
   
   BRYAN ARMITAGE, MD - ORTHOPEDIC SURGEON AT SYNERGY HEALTH
   
   DR. ARMITAGE EARNED HIS MEDICAL DEGREE FROM THE UNIVERSITY OF MINNESOTA,
   MINNEAPOLIS. HE RECEIVED HIS MASTER OF SCIENCE DEGREE IN BIOMEDICAL
   ENGINEERING FROM THE UNIVERSITY OF MINNESOTA, MINNEAPOLIS. HE COMPLETED AN
   ORTHOPEDIC RESIDENCY AT THE UNIVERSITY OF HAWAII, HONOLULU. HE IS SPINE
   FELLOWSHIP TRAINED BY THE TWIN CITIES SPINE CENTER, MINNEAPOLIS. HE IS TRAUMA
   FELLOWSHIP TRAINED BY SWEDISH HOSPITAL IN ENGLEWOOD, COLORADO. PRIOR TO HIS
   MEDICAL DEGREE, DR. ARMITAGE WAS A MEDICAL DEVICE ENGINEER AT BOEHRINGER
   LABORATORIES AND SYNTHES USA. DURING HIS ENGINEERING CAREER, DR. ARMITAGE WAS
   AWARDED MULTIPLE PATENTS COVERING BOTH BIOLOGICS AND IMPLANT DESIGNS. DR.
   ARMITAGE CURRENTLY RESIDES IN THE MINNEAPOLIS/ST. PAUL AREA, AND WHEN HE IS
   NOT SEEING PATIENTS OR OPERATING ON ACUTE TRAUMA PATIENTS, HE CAN USUALLY BE
   FOUND AT HIS OTHER PLACE OF BUSINESS: PARADISE ARCADE. DR. ARMITAGE IS A
   WORLD-RENOWNED DEVELOPER OF ARCADE GAMES AND PARTS.
   
   
   VAHAN SIMONYAN, PH.D. - CHIEF SCIENTIST AT DNAHIVE AND EMBLEEMA
   
   DR. VAHAN SIMONYAN HAS EXPERTISE IN BIOTECHNOLOGY AND BIOMEDICAL INFORMATICS,
   PREVIOUSLY SERVING AT THE FDA AS A LEAD SCIENTIST OF HIVE, R&D DIRECTOR OF
   BIOINFORMATICS. ADDITIONALLY, DR. SIMONYAN IS AN ADJUNCT PROFESSOR AT THE
   GEORGE WASHINGTON UNIVERSITY, WHERE HE TEACHES AND DEVELOPS THE CURRICULUM
   FOR BIOMEDICAL BIG DATA INFORMATICS AND BIOSTATISTICS RESEARCH AND
   DEVELOPMENT COURSES. VAHAN HAS A SOLID SCIENTIFIC BACKGROUND IN VARIED
   ACADEMIC DISCIPLINES: MS IN PHYSICAL ORGANIC CHEMISTRY, PH.D. IN QUANTUM
   PHYSICS AND MATHEMATICS, POST-DOCTORAL TRAINING IN NANOTECHNOLOGY AND QUANTUM
   STATISTICAL THERMODYNAMICS. HE IS A PROLIFIC AUTHOR OF SCIENTIFIC
   PUBLICATIONS IN PHYSICS, CHEMISTRY, QUANTUM CHEMISTRY, NANOTECHNOLOGY,
   BIOTECHNOLOGY, POPULATION DYNAMICS, AND BIOINFORMATICS; AND HE IS A RECIPIENT
   OF MULTIPLE AWARDS, AND MULTIMILLION DOLLAR GRANTS FOR EXCELLENCE IN NUMBER
   OF HEALTH INFORMATICS AND BIOMEDICAL INFORMATICS PROJECTS. VAHAN IS AN
   ADVISOR TO SEVERAL BIOTECH COMPANIES TO NATIONAL GOVERNMENTS IN DIGITAL
   HEALTHCARE. HIS ACCOMPLISHMENTS IN ACADEMIC AND R&D TECHNOLOGY CARRIERS HAVE
   BEEN COMPLEMENTED WITH THE SUCCESS OF TECHNOLOGY LEADERSHIP ROLES IN
   GOVERNMENT, ACADEMIA AND INDUSTRY WHERE HE ESTABLISHES LARGE-SCALE AND
   COMPLEX, SCIENCE-HEAVY R&D INFRASTRUCTURES CAPABLE OF SERVING WORLDWIDE
   COMMUNITIES FOR RESEARCH AND REGULATORY PURPOSES.
   
   
   JEFF DUNKEL- CEO OF OPTAIN
   
   JEFF WAS CHIEF STRATEGY OFFICER FOR TITAN SPINE, AND LED THEIR ACQUISITION OF
   A UNIQUE DESIGNATION OF NANOTECHNOLOGY IN SPINAL IMPLANTS. HE ALSO LED THE
   ORGANIZATION OF STUDIES SHOWING THE CLINICAL BENEFIT OF THEIR SUBTRACTIVE
   SURFACE TECHNOLOGY. THIS LED TO THE ATTAINMENT OF AN ICD-10 CODE TO ALLOW
   HOSPITALS TO BE PAID ADDITIONAL REVENUE FOR PROCEDURES WHERE THEIR IMPLANTS
   ARE USED. HE IS ONE OF THE MOST KNOWLEDGEABLE INDIVIDUALS IN THE UNITED
   STATES IN NANOTECHNOLOGY IN MEDICAL DEVICES. JEFF APPRECIATES THE UNIQUE AND
   POWERFUL NATURE OF OUR BIOBRAILLE SURFACE AND WILL AID US WITH STRATEGIC
   INITIATIVES AND REGULATORY ISSUES RELATED TO ITS SUCCESS AND VALUE
   DEVELOPMENT.
   
   
   TIM GANEY, PH.D. - CHIEF SCIENCE OFFICER OF VIVEX BIOLOGICS
   
   DR. TIM GANEY IS THE INVENTOR OR SPECTRUM SPINE INC'S BIOBRAILLE TECHNOLOGY.
   HE IS A SENIOR ADVISOR TO SPECTRUM, AND IS CURRENTLY EMPLOYED AT VIVEX AS
   CHIEF TECHNICAL OFFICER. HE HAS SERVED AS THE DIRECTOR OF ORTHOPEDIC RESEARCH
   AND DIRECTOR FOR THE RESIDENCY PROGRAM AT ATLANTA MEDICAL CENTER AND DIRECTOR
   OF THE ATLANTA LEARNING CENTER. PRIOR TO HIS TIME AT ATLANTA MEDICAL CENTER
   AND ATLANTA LEARNING CENTER, DR. GANEY SERVED AS THE PRESIDENT OF THE US
   DIVISION OF CO.DON TISSUE ENGINEERING, WHERE HE AND HIS TEAM DEVELOPED AND
   COMMERCIALIZED A PORTFOLIO OF CELL-BASED THERAPEUTICS FOR CARTILAGE AND BONE.
   DR. GANEY HAS BEEN INSTRUMENTAL IN THE DEVELOPMENT OF NUMEROUS TECHNOLOGICAL
   ADVANCEMENTS, INCLUDING THE USE OF CELL-BASED THERAPEUTICS, ELECTRIC FIELD
   TRANSDUCTION, 3D PRINTING, AND PRESCRIBED MATRICES FOR REGENERATIVE MEDICINE.
   HIS NUMEROUS PATENTS INCLUDE WORK IN PULSE-FIELD DELIVERY, ARTIFICIAL
   MATRICES FOR BONE REGENERATION, ELECTRO-SPINNING METHODS AND MATERIALS,
   MIMETIC MATERIAL MODIFICATION USING PHOTOACTIVE LASERS, AND STEM CELL
   PROCUREMENT AND PURIFICATION. APART FROM HIS WORK AT VIVEX BIOLOGICS, DR.
   GANEY IS THE FOUNDER AND CTO AT SPINPLANT GMBH IN LEIPZIG, GERMANY. HE ALSO
   MAINTAINS A FACULTY APPOINTMENT AT THE TRM FACILITY IN LEIPZIG AND IS AN
   ASSOCIATE FACULTY MEMBER AT NOVA SOUTHEASTERN IN FT. LAUDERDALE.


 * INVESTOR INFORMATION
   
   Contact us below for more information 
   
   Contact Us
   Investor Video
   

 * CONTACT US
   
   
   20 Harmony Port, Jasper, GA, 30143
   888-377-7328
   888-377-7328
   sbaltsen@spectrumspine.com
   Name
   Email
   Phone
   Message
   
   Submit
   Comment
   









Cookie Use
We use cookies to ensure a smooth browsing experience. By continuing we assume
you accept the use of cookies.
Accept
Learn More